Shree Ganesh [SGRL] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison

Shree Ganesh Remedies Ltd.

BSE
Loading...

Divi's Laboratories Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Shree Ganesh Remedies Ltd. wins in 7 metrics, Divi's Laboratories Ltd. wins in 11 metrics, with 1 ties. Divi's Laboratories Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Shree Ganesh Remedies Ltd. Divi's Laboratories Ltd. Better
P/E Ratio (TTM) 37.03 67.11 Shree Ganesh Remedies Ltd.
Price-to-Book Ratio 4.36 10.82 Shree Ganesh Remedies Ltd.
Debt-to-Equity Ratio 24.45 0.58 Divi's Laboratories Ltd.
PEG Ratio -0.86 4.63 Divi's Laboratories Ltd.
EV/EBITDA 18.54 48.63 Shree Ganesh Remedies Ltd.
Profit Margin (TTM) 17.99% 24.04% Divi's Laboratories Ltd.
Operating Margin (TTM) 19.25% 29.65% Divi's Laboratories Ltd.
EBITDA Margin (TTM) 19.25% 29.65% Divi's Laboratories Ltd.
Return on Equity 15.89% 14.64% Shree Ganesh Remedies Ltd.
Return on Assets (TTM) 12.02% 12.94% Divi's Laboratories Ltd.
Free Cash Flow (TTM) $74.69M $2.15B Divi's Laboratories Ltd.
Dividend Yield N/A 0.91% N/A
1-Year Return -2.45% -0.43% Divi's Laboratories Ltd.
Price-to-Sales Ratio (TTM) 6.66 16.18 Shree Ganesh Remedies Ltd.
Enterprise Value $6.74B $1,635.46B Divi's Laboratories Ltd.
EV/Revenue Ratio 6.70 15.86 Shree Ganesh Remedies Ltd.
Gross Profit Margin (TTM) 70.00% 63.71% Shree Ganesh Remedies Ltd.
Revenue per Share (TTM) $78 $388 Divi's Laboratories Ltd.
Earnings per Share (Diluted) $14.09 $93.66 Divi's Laboratories Ltd.
Beta (Stock Volatility) 0.19 0.19 Tie

Shree Ganesh Remedies Ltd. vs Divi's Laboratories Ltd. Stock Performance Analysis

Loading Price Chart...

SGRL
DIVISLAB

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Shree Ganesh Remedies Ltd.-5.26%-12.23%-1.17%19.76%24.86%27.80%
Divi's Laboratories Ltd.-0.44%1.34%-2.25%8.85%4.11%4.17%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Shree Ganesh Remedies Ltd.-2.45%64.10%49.51%1,719.55%1,719.55%1,719.55%
Divi's Laboratories Ltd.-0.43%85.44%58.15%496.33%1,610.60%10,946.76%

Performance & Financial Health Analysis: Shree Ganesh Remedies Ltd. vs Divi's Laboratories Ltd.

MetricSGRLDIVISLAB
Market Information
Market Cap i₹6.70B₹1.69T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i4,488253,443
90 Day Avg. Volume i4,536283,911
Last Close₹568.85₹6,608.50
52 Week Range₹381.10 - ₹665.00₹5,636.50 - ₹7,071.50
% from 52W High-14.46%-6.55%
All-Time High₹950.05 (Jul 22, 2024)₹7,071.50 (Jul 08, 2025)
% from All-Time High-40.12%-6.55%
Growth Metrics
Quarterly Revenue Growth-0.22%0.12%
Quarterly Earnings Growth-0.43%-0.01%
Financial Health
Profit Margin (TTM) i0.18%0.24%
Operating Margin (TTM) i0.19%0.30%
Return on Equity (TTM) i0.16%0.15%
Debt to Equity (MRQ) i24.450.58
Cash & Liquidity
Book Value per Share (MRQ)₹119.59₹580.95
Cash per Share (MRQ)₹26.25₹122.95
Operating Cash Flow (TTM) i₹337.14M₹19.67B
Levered Free Cash Flow (TTM) i₹230.68M₹21.91B
Dividends
Last 12-Month Dividend Yield iN/A0.91%
Last 12-Month Dividend i₹0.00₹60.00

Valuation & Enterprise Metrics Analysis: Shree Ganesh Remedies Ltd. vs Divi's Laboratories Ltd.

MetricSGRL (Apr 24, 2026)DIVISLAB (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i37.0367.11
Forward P/E iN/A53.75
PEG Ratio i-0.864.63
Price to Sales (TTM) i6.6616.18
Price to Book (MRQ) i4.3610.82
Market Capitalization
Market Capitalization i₹6.70B₹1.69T
Enterprise Value i₹6.74B₹1.64T
Enterprise Value Metrics
Enterprise to Revenue i6.7015.86
Enterprise to EBITDA i18.5448.63
Risk & Other Metrics
Beta i0.190.19
Book Value per Share (MRQ) i₹119.59₹580.95

Financial Statements Comparison: Shree Ganesh Remedies Ltd. vs Divi's Laboratories Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSGRL (2025)DIVISLAB (2025)
Revenue/Sales i1.07B93.25B
Cost of Goods Sold i361.73M38.70B
COGS % of Revenue i34.0%41.5%
Gross Profit i703.31M54.55B
Gross Margin i66.0%58.5%
Research & Development i2.65M270.00M
Operating Income (EBIT) i301.91M25.71B
Operating Margin i28.3%27.6%
EBITDA i420.76M33.19B
EBITDA Margin i39.5%35.6%
Pre-Tax Income i312.68M29.16B
Pre-Tax Income % of Revenue i29.4%31.3%
Income Tax i81.99M7.25B
Income Tax % of Revenue i7.7%7.8%
Net Income (Profit) i230.68M21.91B
Profit Margin i21.7%23.5%

Balance Sheet & Liquidity Metrics

MetricSGRL (2025)DIVISLAB (2025)
Cash & Equivalents i99.43M4.15B
Total Current Assets i775.75M100.81B
Total Current Assets % of Revenue i72.8%108.1%
Total Current Liabilities i161.82M14.52B
Total Current Liabilities % of Revenue i15.2%15.6%
Long-Term Debt i296.08M20.00M
Long-Term Debt % of Revenue i27.8%0.0%
Total Shareholders Equity i1.45B149.69B
Retained Earnings i1.10B134.00B
Retained Earnings % of Revenue i103.1%143.7%
Property, Plant & Equipment i31.57M3.19B

Cash Flow Statement Comparison

MetricSGRL (2025)DIVISLAB (2025)
Operating Cash Flow i337.14M19.67B
Operating Cash Flow % of Revenue i31.7%21.1%
Capital Expenditures i-231.76M-14.38B
Free Cash Flow i74.69M2.15B
FCF Margin i7.0%2.3%
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSGRLDIVISLAB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i12.84M265.47M
Float Shares i3.09M117.72M
% Held by Insiders i75.92%52.04%
% Held by Institutions i0.00%28.65%
% Held by Public i24.08%19.31%

Dividend Analysis & Yield Comparison: Shree Ganesh Remedies Ltd. vs Divi's Laboratories Ltd.

MetricSGRLDIVISLAB
Last 12-Month Dividend i₹0.00₹60.00
Last 12-Month Dividend Yield iN/A0.91%
3-Year Avg Annual Dividend i₹0.33₹50.00
3-Year Avg Dividend Yield i0.15%0.70%
3-Year Total Dividends i₹1.00₹150.00
Ex-Dividend DateSep 07, 2023Jul 25, 2025